These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 27445086)

  • 1. Xenogeneic cardiac extracellular matrix scaffolds with or without seeded mesenchymal stem cells exhibit distinct in vivo immunosuppressive and regenerative properties.
    Papalamprou A; Chang CW; Vapniarsky N; Clark A; Walker N; Griffiths LG
    Acta Biomater; 2016 Nov; 45():155-168. PubMed ID: 27445086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Extracellular Matrix Scaffold Generated Using Sarcomeric Disassembly and Antigen Removal.
    Papalamprou A; Griffiths LG
    Ann Biomed Eng; 2016 Apr; 44(4):1047-60. PubMed ID: 26215309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-specific immune tolerance is determined by residual antigenicity of xenogeneic extracellular matrix scaffolds.
    Dalgliesh AJ; Parvizi M; Lopera-Higuita M; Shklover J; Griffiths LG
    Acta Biomater; 2018 Oct; 79():253-264. PubMed ID: 30130615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix liver scaffolds.
    Sabetkish S; Kajbafzadeh AM; Sabetkish N; Khorramirouz R; Akbarzadeh A; Seyedian SL; Pasalar P; Orangian S; Beigi RS; Aryan Z; Akbari H; Tavangar SM
    J Biomed Mater Res A; 2015 Apr; 103(4):1498-508. PubMed ID: 25045886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo xenogeneic scaffold fate is determined by residual antigenicity and extracellular matrix preservation.
    Wong ML; Wong JL; Vapniarsky N; Griffiths LG
    Biomaterials; 2016 Jun; 92():1-12. PubMed ID: 27031928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen removal process preserves function of small diameter venous valved conduits, whereas SDS-decellularization results in significant valvular insufficiency.
    Lopera Higuita M; Griffiths LG
    Acta Biomater; 2020 Apr; 107():115-128. PubMed ID: 32151701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decellularization with triton X-100 provides a suitable model for human kidney bioengineering using human mesenchymal stem cells.
    Shahraki S; Bideskan AE; Aslzare M; Tavakkoli M; Bahrami AR; Hosseinian S; Matin MM; Rad AK
    Life Sci; 2022 Apr; 295():120167. PubMed ID: 34822795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifying decellularized aortic valve scaffolds with stromal cell-derived factor-1α loaded proteolytically degradable hydrogel for recellularization and remodeling.
    Dai J; Qiao W; Shi J; Liu C; Hu X; Dong N
    Acta Biomater; 2019 Apr; 88():280-292. PubMed ID: 30721783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward allogenizing a xenograft: Xenogeneic cardiac scaffolds recellularized with human-induced pluripotent stem cells do not activate human naïve neutrophils.
    Al-Hejailan RS; Bakheet RH; Al-Saud MM; Al-Jufan MB; Al-Hindas HM; Al-Qattan SM; Al-Muhanna MK; Parhar RS; Conca W; Hansmann J; Collison KS; Walles H; Al-Mohanna FA
    J Biomed Mater Res B Appl Biomater; 2022 Mar; 110(3):691-701. PubMed ID: 34619017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of cardiac extracellular matrix scaffolds by decellularization of human myocardium.
    Oberwallner B; Brodarac A; Choi YH; Saric T; Anić P; Morawietz L; Stamm C
    J Biomed Mater Res A; 2014 Sep; 102(9):3263-72. PubMed ID: 24142588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sterilization method for decellularized xenogeneic cardiovascular scaffolds.
    Fidalgo C; Iop L; Sciro M; Harder M; Mavrilas D; Korossis S; Bagno A; Palù G; Aguiari P; Gerosa G
    Acta Biomater; 2018 Feb; 67():282-294. PubMed ID: 29183849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal Extracellular Matrix Supports Cardiac Differentiation of Embryonic Stem Cells: a Potential Scaffold for Engineered Cardiac Tissue.
    Hong X; Yuan Y; Sun X; Zhou M; Guo G; Zhang Q; Hescheler J; Xi J
    Cell Physiol Biochem; 2018; 45(1):319-331. PubMed ID: 29402858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nonhuman primate model of lung regeneration: detergent-mediated decellularization and initial in vitro recellularization with mesenchymal stem cells.
    Bonvillain RW; Danchuk S; Sullivan DE; Betancourt AM; Semon JA; Eagle ME; Mayeux JP; Gregory AN; Wang G; Townley IK; Borg ZD; Weiss DJ; Bunnell BA
    Tissue Eng Part A; 2012 Dec; 18(23-24):2437-52. PubMed ID: 22764775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity analysis of decellularized cardiac scaffolds after transplantation into rats.
    Tong C; Xia J; Xie B; Li M; Du F; Li C; Li Y; Shan Z; Qi Z
    Regen Med; 2019 May; 14(5):447-464. PubMed ID: 31070505
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of biological meniscus scaffold: Decellularization method and recellularization with meniscal cell population derived from mesenchymal stem cells.
    Kara A; Koçtürk S; Bilici G; Havitcioglu H
    J Biomater Appl; 2021 Apr; 35(9):1192-1207. PubMed ID: 33444085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acellular cardiac extracellular matrix as a scaffold for tissue engineering: in vitro cell support, remodeling, and biocompatibility.
    Eitan Y; Sarig U; Dahan N; Machluf M
    Tissue Eng Part C Methods; 2010 Aug; 16(4):671-83. PubMed ID: 19780649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse.
    Alshaikh AB; Padma AM; Dehlin M; Akouri R; Song MJ; Brännström M; Hellström M
    Reprod Biol Endocrinol; 2020 Jul; 18(1):75. PubMed ID: 32703228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of protein solubilization in antigen removal from xenogeneic tissue for heart valve tissue engineering.
    Wong ML; Leach JK; Athanasiou KA; Griffiths LG
    Biomaterials; 2011 Nov; 32(32):8129-38. PubMed ID: 21810537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decellularized cartilage-derived matrix as substrate for endochondral bone regeneration.
    Gawlitta D; Benders KE; Visser J; van der Sar AS; Kempen DH; Theyse LF; Malda J; Dhert WJ
    Tissue Eng Part A; 2015 Feb; 21(3-4):694-703. PubMed ID: 25316202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cell Seeding of Porcine Small Intestinal Submucosal Extracellular Matrix for Cardiovascular Applications.
    Chang CW; Petrie T; Clark A; Lin X; Sondergaard CS; Griffiths LG
    PLoS One; 2016; 11(4):e0153412. PubMed ID: 27070546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.